Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Franco Locatelli, MD, Maria Ester Bernardo, MD, Alice Bertaina, MD PhD, Carla Rognoni, PhD, Patrizia Comoli, MD, Attilio Rovelli, MD, Andrea Pession, MD PhD, Franca Fagioli, MD, Claudio Favre, MD, Edoardo Lanino, MD, Giovanna Giorgiani, MD, Pietro Merli, MD, Arcangelo Prete, MD, Marco Zecca, MD

Blood (2016) 128 (22): 1168.

https://doi.org/10.1182/blood.V128.22.1168.1168

Published: 2016

Journal Articles

Targeted Inhibition of mTORC1 and mTORC2 by the Active-Site mTOR Inhibitors, PP-242 and OSI-027, Has Cytotoxic Effects In T-Cell Acute Lymphoblastic Leukemia

Camilla Evangelisti, PhD, Francesca Chiarini, PhD, Francesca Ricci, BS, Pierluigi Tazzari, MD, Andrea Pession, MD, PhD, James A McCubrey, PhD, Alberto M. Martelli, MD

Blood (2010) 116 (21): 3242.

https://doi.org/10.1182/blood.V116.21.3242.3242

Published: 2010

Journal Articles

AMP-Dependent Kinase/mTOR Complex 1 Signaling In T-Cell Acute Lymphoblastic Leukemia: Therapeutical Implications

Cecilia Grimaldi, BS, Francesca Chiarini, PhD, Francesca Ricci, BS, Pierluigi Tazzari, MD, Michela Battistelli, PhD, Elisabetta Falcieri, MD, Andrea Pession, MD, PhD, James McCubrey, PhD, Alberto M. Martelli, MD

Blood (2010) 116 (21): 3225.

https://doi.org/10.1182/blood.V116.21.3225.3225

Published: 2010

Journal Articles

Dual Inhibition of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin with NVP-BEZ235 as a New Therapeutic Option for T-Cell Acute Lymphoblastic Leukemia.

Francesca Chiarini, BS, Cecilia Grimaldi, BS, Francesca Ricci, BS, Pierluigi Tazzari, MD, Camilla Evangelisti, PhD, Andrea Pession, MD, PhD, Pasqualepaolo Pagliaro, MD, James McCubrey, PhD, Alberto M. Martelli, MD

Blood (2009) 114 (22): 2025.

https://doi.org/10.1182/blood.V114.22.2025.2025

Published: 2009

Journal Articles

Prevalence and Clinical Correlates of JAK2 Mutations in Pediatric Down Syndrome Acute Lymphoblastic Leukemia.

Amos S. Gaikwad, PhD, Cassia L. Rye, Meenakshi Devidas, PhD, Shai Izraeli, Sr., MD, Sharon E. Plon, MD, PhD, Giuseppe Basso, MD, Andrea Pession, MD, PhD, Karen R. Rabin, MD

Blood (2008) 112 (11): 1506.

https://doi.org/10.1182/blood.V112.11.1506.1506

Published: 2008

Journal Articles

Gene Expression Profiling Differentiates Childhood Acute Lymphoblastic Leukemia in Down Syndrome Versus Non-Down Syndrome Patients.

Karen R. Rabin, MD, Jinhua Wang, PhD, Anna Tsimelzon, PhD, Debra Morrison, PhD, Amos S. Gaikwad, PhD, Laura Hogan, MD, Cassia L. Rye, Susan G. Hilsenbeck, PhD, Meenakshi Devidas, PhD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Giuseppe Basso, MD, William L. Carroll, MD, Andrea Pession, MD, PhD, Deepa Bhojwani, MD

Blood (2008) 112 (11): 1203.

https://doi.org/10.1182/blood.V112.11.1203.1203

Published: 2008

Journal Articles

PI-103, a Dual Inhibitor of Class IA Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin, Has Cytotoxic Activity in T-Cell Acute Lymphoblastic Leukemia Cells: A New Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia.

Francesca Chiarini, BS, Federica Fala, PhD, Francesca Ricci, BS, PierLuigi Tazzari, MD, Annalisa Astolfi, PhD, Andrea Pession, MD, PhD, James McCubrey, PhD, Alberto M. Martelli, MD

Blood (2008) 112 (11): 1921.

https://doi.org/10.1182/blood.V112.11.1921.1921

Published: 2008

Journal Articles

Retrospective Evaluation of 90 Children with Essential Thrombocytemia: The AIEOP Experience

Maria Caterina Putti, MD, Fiorina Giona, MD, Caterina Consarino, MD, Gian Mario Fiori, MD, Paola Giordano, MD, Saverio Ladogana, MD, Momcilo Jankovic, MD, Concetta Micalizzi, MD, Andrea Pession, MD, PhD, Paolo Pierani, MD, Ugo Ramenghi, MD, Margherita Scapin, PhD, Luciana Teofili, MD, Fabio Tucci, MD, Katia Tettoni, MD, Andrea Giulio Zanazzo, Maria Luigia Randi, MD

Blood (2008) 112 (11): 664.

https://doi.org/10.1182/blood.V112.11.664.664

Published: 2008

Journal Articles

G1 Cell-Cycle Arrest and Apoptosis by Histone Deacetylase Inhibition in MLL-AF9 Acute Myeloid Leukemia Cells Is MLL-AF9 Independent.

Roberto Tonelli, PhD, Roberta Sartini, PhD, Raffaele Fronza, PhD, Francesca Freccero, PhD, Monica Franzoni, PhD, Danilo Dongiovanni, PhD, Marco Ballarini, PhD, Simona Ferrari, PhD, Maria D’Apolito, PhD, Gabriella Di Cola, PhD, Giovanni Capranico, PhD, Andriy Khobta, PhD, Renato Campanini, PhD, Paolo Paolucci, MD, Saverio Minucci, MD, Andrea Pession, MD, PhD

Blood (2005) 106 (11): 4410.

https://doi.org/10.1182/blood.V106.11.4410.4410

Published: 2005

Journal Articles

Trisomy 11 and Partial Tandem Duplication of the MLL Gene in a Case of Infant Acute Myeloid Leukemia M0.

Salvatore Serravalle, PhD, Stefania Purgato, PhD, Fraia Melchionda, MD, Roberto Tonelli, PhD, Andrea Pession, MD, PhD

Blood (2005) 106 (11): 4474.

https://doi.org/10.1182/blood.V106.11.4474.4474

Published: 2005

Journal Articles

Identification of a New t(4;11) Rearrangement Involving MLL and ArgBP2 in a Case of Infant Acute Myeloid Leukemia.

Roberto Tonelli, PhD, Luca Lo Nigro, MD, Salvatore Serravalle, PhD, Luca Montemurro, PhD, Giancarlo Izzi, MD, Andrea Pession, MD, PhD

Blood (2004) 104 (11): 4331.

https://doi.org/10.1182/blood.V104.11.4331.4331

Published: 2004

NARROW

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Targeted Inhibition of mTORC1 and mTORC2 by the Active-Site mTOR Inhibitors, PP-242 and OSI-027, Has Cytotoxic Effects In T-Cell Acute Lymphoblastic Leukemia

AMP-Dependent Kinase/mTOR Complex 1 Signaling In T-Cell Acute Lymphoblastic Leukemia: Therapeutical Implications

Dual Inhibition of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin with NVP-BEZ235 as a New Therapeutic Option for T-Cell Acute Lymphoblastic Leukemia.

Prevalence and Clinical Correlates of JAK2 Mutations in Pediatric Down Syndrome Acute Lymphoblastic Leukemia.

Gene Expression Profiling Differentiates Childhood Acute Lymphoblastic Leukemia in Down Syndrome Versus Non-Down Syndrome Patients.

PI-103, a Dual Inhibitor of Class IA Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin, Has Cytotoxic Activity in T-Cell Acute Lymphoblastic Leukemia Cells: A New Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia.

Retrospective Evaluation of 90 Children with Essential Thrombocytemia: The AIEOP Experience

G1 Cell-Cycle Arrest and Apoptosis by Histone Deacetylase Inhibition in MLL-AF9 Acute Myeloid Leukemia Cells Is MLL-AF9 Independent.

Trisomy 11 and Partial Tandem Duplication of the MLL Gene in a Case of Infant Acute Myeloid Leukemia M0.

Identification of a New t(4;11) Rearrangement Involving MLL and ArgBP2 in a Case of Infant Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only